These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3242060)

  • 1. [Anticholinergic antiparkinson agents].
    Taurand P
    Soins Psychiatr; 1988 Nov; (97):I-II. PubMed ID: 3242060
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use in psychiatry of antiparkinson drugs].
    Bourgeois M; Mazaux JM; Imbert D; Daubech MJ; Daulouède JP; Tignol J
    Ann Med Psychol (Paris); 1976 Oct; 2(3):499-510. PubMed ID: 1020859
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of anticholinergic medication to symptom change in schizophrenia.
    DeQuardo JR; Kloss RJ
    J Clin Psychiatry; 1993 Sep; 54(9):356-7. PubMed ID: 8407855
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiparkinson agents].
    Staal-Schreinemachers AL; Lakke JP
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):228-30. PubMed ID: 3561558
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioreceptor assay of anticholinergic drugs.
    Iisalo E; Kaila T; Laurén L
    Ann Clin Res; 1988; 20(5):367-72. PubMed ID: 3218907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug information: antiparkinson agents. I. Anticholinergic agents].
    Veje VO
    Sygeplejersken; 1981 Sep; 81(34):11. PubMed ID: 6913222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antocholinergic antiparkinsonic drugs in contemporary psychiatry (author's transl)].
    Dolezalová B; Vacek J
    Cesk Psychiatr; 1975 Dec; 71(6):398-403. PubMed ID: 1218434
    [No Abstract]   [Full Text] [Related]  

  • 8. Nosological and prognostic distinctions in schizophrenia: pharmacological validation in terms of therapeutic antagonism between anticholinergic anti-parkinsonism drugs and neuroleptics.
    Singh MM; Kay SR
    Neuropsychobiology; 1978; 4(5):288-304. PubMed ID: 673165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiparkinsonian drugs (author's transl)].
    Ando K
    No To Shinkei; 1980 Aug; 32(8):743-53. PubMed ID: 7008813
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of schemes of systematized description of changes in tonus and hyperkinesis for clinico-physiologic evaluation of the action of enurotropic pharmacologic preparations].
    Kambarova DK; Anichkov AD; Moiseeva NI; Movsisiants SA
    Sov Zdravookhr Kirg; 1971; 3():34-40. PubMed ID: 5151501
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C; Dimascio A; Demirgian E
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathochemical bases for the treatment of parkinsonism].
    Petelin LS; Tret'iakova KA; Pigarev VA; Romenskaia LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1765-70. PubMed ID: 5143959
    [No Abstract]   [Full Text] [Related]  

  • 13. The drug treatment of Parkinson's disease.
    Drug Ther Bull; 1984 May; 22(10):37-40. PubMed ID: 6745095
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease; modern treatment.
    Tolosa E
    Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Parkinson's disease.
    Hardie R
    Br J Hosp Med; 1985 Jan; 33(1):45-6, 48-9. PubMed ID: 3882178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of Parkinson's disease.
    Burton K; Calne DB
    Neurol Clin; 1984 Aug; 2(3):461-72. PubMed ID: 6152482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 19. [A method to diagnose tremor manifestations and its therapeutic modification].
    Steinbrecher W
    Med Welt; 1973 Feb; 24(7):237-40. PubMed ID: 4731688
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.